opioides

For Immediate Release: May 24, 2023 Today, the U.S. Food and Drug Administration (FDA) approved the extended-release Brixadi (buprenorphine) subcutaneous (for use under the skin) injection to treat moderate to severe opioid use disorder...

Document of the Ministry of Health and Social Protection of Colombia that presents baseline of the maintenance programs with methadone in the country and the profile of the population served and the general characteristics of the treatment...

Global drug consumption increases, while COVID-19 impacts markets, according to the World Drug Report 2020, released on June 25, 2020 by the United Nations Office on Drugs and Crime (UNODC). The Report shows that around 269 million people...

Equipa a los proveedores de atención médica, las comunidades y los gobiernos locales con materiales para desarrollar prácticas y políticas para ayudar a prevenir las sobredosis y las muertes relacionadas con los opioides. Aborda diferentes...